Nkarta, Inc.

About Nkarta, Inc.

Nkarta Inc. is dedicated to realizing the potential of natural killer (NK) cells for the treatment of autoimmune diseases. Their proprietary technology harnesses the power of these immune cells to search and destroy dysfunctional or diseased cells, aiming to develop next-generation cell therapies.

Products & Services

Engineered and Enhanced NK Cells:NK cells modified to enhance their pathogen-fighting capabilities for therapeutic use.

Proprietary Expansion Technology:A unique technology to expand NK cells, increasing their applicability in treatments.

Cell Therapies for Autoimmune Diseases:Next-generation therapies leveraging NK cells to treat autoimmune conditions, with potential to reach more patients.

Specialties

Natural Killer (NK) Cell Therapy Autoimmune Disease Treatment Cell Therapy Development NK Cell Expansion Technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Underwritten Offering T: - FT: Underwritten Offering	A: 240100000 MR: - FA: approximately $240.1 million FAN: 240100000	D: 2024-03-25 FD: 2024-03-25	13 investors

Underwritten Offering Latest

2024-03-25

$240.1M

13 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

P

Paul J. Hastings

Chief Executive Officer

N

Nadir Mahmood

PRESIDENT

S

Shawn Rose

Chief Medical Officer and Head of Research & Development

A

Ali Behbahani

Partner at NEA and Co-founder of Nkarta

M

Mike Dybbs

Partner

S

Simeon George

CEO of SR One

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Nkarta, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised